Expediting drug approval

| May 19, 2017

article image
In recent years, FDA has made great advances in the review of new drugs. From 2012 to 2015, FDA approved a record number of marketing applications for novel drugs, averaging 38 approved products per year. In 2016, FDA approved only 22 novel drugs but the percentage of applications leveraging an expedited program was at its highest.

Spotlight

Quest Nutra Pharma Group

Quest Nutra Pharma is a manufacturer of nutraceuticals, pharmaceuticals, food supplements, botanical extracts and flavours, with factories and entities in the United Kingdom and the United Arab Emirates. The group has its own brands of nutraceuticals and pharmaceuticals, offers contract manufacturing services to other businesses, and also supplies the pharmaceutical, agricultural and food industries with flavours and botanical extracts. The operating entities within the group consist of Quest Vitamins Ltd, Quest Ingredients Ltd (formerly Flavex International Ltd) and Quest Middle East FZE. The factories within the group are certified with pharmaceutical-grade GMP by the UK's Medicines and Healthcare products Regulatory Agency (MHRA) and by other regulators around the world. The factories also have certifications for BRC Grade A, ISO 9001, FEMAS and SEDEX.

OTHER ARTICLES

Advance Your Pharma Supply Chain Planning during a Pandemic

Article | March 20, 2020

One predominant and common element within our pharmaceutical industry, is our devotions to patients. Within supply chain there is always a focus on ensuring the right product is delivered to the right place at the right time in order to ensure patient safety and the continuity of medicinal supplies. With the spread of COVID-19 across 117 countries and counting, every supply chain needs to evaluate their global footprint and develop contingency plans within their end to end operations.

Read More

What to Watch in 2020: Non-Specialty Drugs

Article | March 1, 2020

Pharmaceutical manufacturers are constantly working to develop new and improved medications. Join us as we explore the non-specialty drugs you should be watching in 2020. If you missed last week’s article about the most important upcoming specialty drugs, be sure to check it out here. Approximately 40 new medications are approved by the Food and Drug Administration (FDA) every year.1 (Please note: If you’re curious about what it takes to develop a drug and bring it to market, check out our previous article). Why should you care about these new medications? Because they can affect both your organization’s pharmacy spend and your members’ cost share. For non-specialty drugs, we will focus on medications that may come to market this year, including ones that are currently being reviewed by the FDA, or that are in the last clinical trial (Phase III) stage.

Read More

Coronavirus Pandemic Brings Hundreds Of U.S. Clinical Trials To A Halt

Article | April 11, 2020

Rene Roach fired off a quick email in late March for an update on a colorectal cancer clinical trial for which she hoped to qualify. Worried about the coronavirus, she asked, almost as an afterthought, whether the study had been put on hold because of the pandemic.The answer crushed her: It had been. "That's when COVID-19 shut down everything," says Roach, 50, of Germantown, Md. Roach assumed that there would be workarounds for patients like her, who have stage IV cancer. These patients often depend on clinical trials as their best chance to knock cancer out when other therapies have failed. For now, she's being treated with traditional chemotherapy, but she was counting on the drug cocktail from the clinical trial. She figures if chemo was going to rid her body of cancer for good, it would have done so already.

Read More

Global Antiviral Drugs Market Growth: Is Antiviral Drug the Best Coronavirus Treatment?

Article | April 9, 2020

The global antiviral drugs market has witnessed a rapid surge in demand due to the ongoing Covid-19 pandemic worldwide. So is antiviral drug the best coronavirus treatment? It is still too early to have that conclusion as many medical research and clinical trials are still trying to find the effectiveness and potential side effects of using antiviral drugs to treat coronavirus. But experts believe that antiviral drug might be the best hope for reduce the coronavirus transmission around the world at this stage. However, due to the current difficult situation of the supply chain in many lockdown countries and regions, there is a global shortage on the antiviral drugs supply. With researchers and manufacturers working hard to find and provide effective coronavirus treatment, it is expected that the global antiviral drugs market will have a significant growth over the near future. Antiviral drugs are a type of medication used specifically for treating viral infections, such as human immunodeficiency virus (HIV), hepatitis, and influenza.

Read More

Spotlight

Quest Nutra Pharma Group

Quest Nutra Pharma is a manufacturer of nutraceuticals, pharmaceuticals, food supplements, botanical extracts and flavours, with factories and entities in the United Kingdom and the United Arab Emirates. The group has its own brands of nutraceuticals and pharmaceuticals, offers contract manufacturing services to other businesses, and also supplies the pharmaceutical, agricultural and food industries with flavours and botanical extracts. The operating entities within the group consist of Quest Vitamins Ltd, Quest Ingredients Ltd (formerly Flavex International Ltd) and Quest Middle East FZE. The factories within the group are certified with pharmaceutical-grade GMP by the UK's Medicines and Healthcare products Regulatory Agency (MHRA) and by other regulators around the world. The factories also have certifications for BRC Grade A, ISO 9001, FEMAS and SEDEX.

Events